Cavu Advisors, LLC is 10% Owner at Lantern Pharma Inc. (LTRN). They have made 5 open-market trades across 3 companies since 2022, most recently 2025-06-12.
CIK 0001813310
2 open-market purchases totalling $3.2M since 2022, against 3 sales. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| LTRN | SELL | 2025-06-10 | 2025-06-13 | $3.38 | $344K | +1.3% | +28.7% | +26.8% |
| LTRN | SELL | 2025-05-27 | 2025-05-29 | $2.99 | $168K | +8.7% | +1.9% | +30.6% |
| LTRN | SELL | 2024-05-23 | 2024-05-28 | $6.30 | $189K | -9.3% | -26.2% | -24.4% |
| AZTR | BUY | 2023-06-21 | 2023-06-23 | $5.00 | $3.0M | -18.1% | -15.2% | -64.1% |
| INAB | BUY | 2022-08-26 | 2022-08-30 | $2.02 | $165K | -2.6% | -21.8% | -40.5% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.